Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	46
Overall Study	STARTED	SPD489 5 mg	40
Overall Study	STARTED	SPD489 10 mg	37
Overall Study	STARTED	SPD489 20 mg	37
Overall Study	STARTED	SPD489 30 mg	39
Overall Study	Received Treatment	Placebo	45
Overall Study	Received Treatment	SPD489 5 mg	39
Overall Study	Received Treatment	SPD489 10 mg	35
Overall Study	Received Treatment	SPD489 20 mg	34
Overall Study	Received Treatment	SPD489 30 mg	38
Overall Study	COMPLETED	Placebo	37
Overall Study	COMPLETED	SPD489 5 mg	32
Overall Study	COMPLETED	SPD489 10 mg	26
Overall Study	COMPLETED	SPD489 20 mg	30
Overall Study	COMPLETED	SPD489 30 mg	25
Overall Study	NOT COMPLETED	Placebo	9
Overall Study	NOT COMPLETED	SPD489 5 mg	8
Overall Study	NOT COMPLETED	SPD489 10 mg	11
Overall Study	NOT COMPLETED	SPD489 20 mg	7
Overall Study	NOT COMPLETED	SPD489 30 mg	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03260205/flow